Name: Rapport Therapeutics, Inc. (RAPP) Balance Sheet
Creator: FinSpry

Rapport Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Rapport Therapeutics, Inc. (RAPP) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	56.81	70.17	31.16
Short-Term Investments	248.48	77.31	0.00
Cash & Short-Term Investments	305.28	147.48	31.16
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	4.52	1.50	0.11
Total Current Assets	309.80	150.87	31.27
Non-Current Assets
Property, Plant & Equipment (Net)	4.97	4.00	0.34
Other Non-Current Assets	0.16	0.25	0.00
Total Non-Current Assets	5.13	4.55	0.34
Total Assets	314.93	155.42	31.60
Current Liabilities
Accounts Payable	1.95	2.50	1.45
Short-Term Debt	0.74	0.00	0.00
Accrued Liabilities	2.37	5.63	0.21
Other Current Liabilities	6.08	0.00	0.00
Total Current Liabilities	8.77	8.80	1.66
Non-Current Liabilities
Long-Term Debt	0.74	4.20	10.44
Other Non-Current Liabilities	0.00	0.00	0.00
Total Non-Current Liabilities	0.74	172.25	40.00
Total Liabilities	9.51	14.48	41.67
Stockholders' Equity
Common Stock	0.04	0.00	0.00
Retained Earnings	-123.75	-45.44	-10.65
Accumulated Other Comprehensive Income	-0.52	0.00	0.00
Additional Paid-in Capital	429.66	19.80	0.59
Shares Outstanding	36.58	35.38	35.38
Total Stockholders' Equity	305.43	140.94	-10.06
Total Liabilities & Equity	314.93	155.42	31.60